EURE-CART Project

Multicentre #clinicaltrial to demonstrate the safety and efficacy of CD44v6 #CARTcell #immunotherapy in acute #MyeloidLeukaemia and #MultipleMyeloma.

[EURE-CART Project @EURECART_EU]

Dear Followers, as the #EURECART_EU project has come to an end we will close this twitter account. Thank you for following us and we hope to see you again in future😀

[EBMT @TheEBMT]

Welcome to Day 3️⃣, the final day of the #EBMT-@EHA_Hematology 4th European CAR T-cell Meeting. What has been your favourite session so far? 🤔 Tell us in the replies! 💬

Thank you to all #CART22 meeting participants and we hope to see you again soon at #EBMT22 and #CART23 👋

[T2EVOLVE @t2evolve_imi]

Congratulations to Dr. Maik Luu of the Hudecek lab, part of #T2EVOLVE, who was among the three awardees for the 2nd Emerging Investigators #EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy for his work on the microbiome-CAR T cell interface. #CART22

[CARAMBA @CARAMBA_project]

J. Beckmann shares her experience on multinational clinical trials such as CARAMBA in the Trial Management session at the 4th CART Cell Meeting, today at 12:20. #CART22

[CARAMBA @CARAMBA_project]

“How to set up and run a CART unit?” – listen to presentations by our CARAMBA partners Fabio Ciceri and Halvard Bönig, chaired by Ibrahim Yakoub-Agha and Mark Hunter. #CART22

[VJHemOnc @VJHemOnc]

It’s day 2 of #CART22! With so many interesting topics to discuss, you won’t want to miss out. Join us while we interview multiple experts in the field of #CARTtherapy.

@TheEBMT @EHA_Hematology #CART #ImmunoOnc #HemOnc #tcellrx #MMsm #LYMsm #AMLsm #CARTcell #CARTcells 👩‍🔬👨‍🔬

[EBMT @TheEBMT]

Welcome to Day 2️⃣ of the #EBMT-@EHA_Hematology 4th European CAR T-cell Meeting. Today we will be live from 9:00-20:15 CET 🎬. Don't miss out on the day's Nursing ⚕️ Sessions and more!

And stay tuned until tomorrow for our post on Saturday's Scientific Programme #CART22

[Ibrahim Yakoub-Agha @i_yakoub_agha]

Looking forward to meeting you at EBMT/EHA 2022CART meeting @TheEBMT @TheEBMT_Trainee @JACIE_EBMT @NicoGagelmann @AnnaSureda5 @eha_news @CARAMBA_project @Mohty_EBMT @CChabannon @BldCancerDoc @drjgauthier @DrMiguelPerales @drclaireroddie @pjhayden

[T2EVOLVE @t2evolve_imi]

#T2EVOLVE is composed of 27 partners from research facilities, public bodies, pharmaceutical & biotechnology companies, to much more. Join us throughout February as we dive into our partners' unique perspectives on the field of #CART.
Learn more: https://t.co/vAmCCI81fm

[VJHemOnc @VJHemOnc]

Next week, we will be interviewing many experts in the forefront of #CARTtherapy at the 2022 4th European CAR T-Cell meeting. Are you as excited as we are?🥳 Follow us on @VJHemOnc for more!

@TheEBMT @EHA_Hematology #CART22 #CART #ImmunoOnc #HemOnc #tcellrx #CARTcell #MMsm

[CARAMBA @CARAMBA_project]

So excited - next week the 4th European #CARTcell Meeting will be chaired by CARAMBA coordinator Prof Michael Hudecek and CARAMBA partner Prof Ibrahim Yakoub-Agha. Registration is still open for this fully virtual event: https://t.co/vVjZs8Nwuh

[Myeloma Patients Europe @MyelomaEurope]

As part of the @CARAMBA_project, MPE is conducting two research projects.
If you want to participate in our focus group discussions on November 24th, click here: https://t.co/x1hm7Ij9Us

[CARAMBA @CARAMBA_project]

From 10-12 February 2022, the 4th European CAR T-Cell Meeting #CART22 will take place in Nice, France (online attendance possible). CARAMBA will be represented!
🚩Preliminary programme: https://t.co/gUEjLPj8SR
➡️Registration: https://t.co/RxatSU6EXO
#CART #CARTcells #bloodcancer

[CARAMBA @CARAMBA_project]

Congratulations to Monica Casucci and her team for publishing their great results on blocking malignant N-glycosylation to improve #CARTcell therapy:
https://t.co/N5YA8PDGFM

[Myeloma Patients Europe @MyelomaEurope]

As part of patient research within the @CARAMBA_project Consortium, MPE is conducting 2 research projects. If you're a patient or carer, join the discussions and share your #CART experiences in our focus groups in English, Spanish, and French.
Click here▶️https://t.co/xPoCnq1RWF

[European Hematology Association @EHA_Hematology]

#CART22: You can now explore the full program for the 4th European CAR T-cell Meeting online➡️ https://t.co/YuaXNPIUM7. Topics run from clinical indications of #CARTtherapy and new data and trials in the pipeline to treatment updates and next-generation CAR-T therapy.

[PNO Innovation Germany @PNO_Inno_DE]

THANK YOU for your trust in us in 2021! We are looking forward to renewing our partnerships with you in 2022. A happy, fulfilling and prosperous new year from all of us at ARTTIC Innovation!
@CORDIS_EU @PNOconsultants @PnoEurope

[CARAMBA @CARAMBA_project]

Abstract submission is now open for 4th CAR T-cell meeting #CART22. We hope to see you there!

[European Hematology Association @EHA_Hematology]

Early bird registration for the 4th European CAR T-Cell Meeting #CART22 is now open. The hybrid format means you can attend physically & interact live or join via the online platform. Physical participants will also get virtual materials access. @TheEBMT
https://t.co/dUwqTxTG6I

[T2EVOLVE @t2evolve_imi]

New targets are a crucial need for the development of new immunotherapy approaches. Recent work identified Siglec-6 as a novel target for CAR T cells in the context of acute myeloid leukemia.Take a look at the study: https://t.co/Q7H1UFtu0m

#research #cancertherapy #CART